Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.

Thomas Wj HuizingaErnest ChoyAmy PraestgaardHubert van HoogstratenPatrick R LaFontainePatricia GuyotDaniel AletahaUlf Müller-LadnerYoshiya TanakaJeffrey R CurtisRoy Fleischmann

Published in: Rheumatology and therapy (2023)

In the MAIC and STC analyses from TARGET and SELECT-BEYOND trials, the efficacy of sarilumab and upadacitinib were comparable.

Keyphrases

clinical evaluation
preterm birth